<?xml version="1.0" encoding="UTF-8"?><document xmlns="http://uk.gov.dstl/baleen/parse" uri="https://dstl.github.io/eleatics/argumentation/coronavirus/information.xhtml#biosafety"><text>The three laboratories in Wuhan working with either CoVs diagnostics and/or CoVs isolation and vaccine development all had high quality biosafety level (BSL3 or 4) facilities that were well-managed, with a staff health monitoring programme with no reporting of COVID-19 compatible respiratory illness during the weeks/months prior to December 2019, and no serological evidence of infection in workers through SARS-CoV-2-specific serology-screening.</text><sentence begin="0" end="448" num="1"><token begin="0" end="3" id="4"><surface>The</surface><lemma penn="DT"/><dependent governor="6" type="det"/></token><token begin="4" end="9" id="5"><surface>three</surface><lemma penn="CD"/><dependent governor="6" type="nummod"/></token><token begin="10" end="22" id="6"><surface>laboratories</surface><lemma penn="NNS">laboratory</lemma><dependent governor="31" type="nsubj"/></token><token begin="23" end="25" id="7"><surface>in</surface><lemma penn="IN"/><dependent governor="8" type="case"/></token><token begin="26" end="31" id="8"><surface>Wuhan</surface><lemma penn="NNP">wuhan</lemma><dependent governor="6" type="nmod"/></token><token begin="32" end="39" id="9"><surface>working</surface><lemma penn="VBG">work</lemma><dependent governor="6" type="acl"/></token><token begin="40" end="44" id="10"><surface>with</surface><lemma penn="IN"/><dependent governor="13" type="case"/></token><token begin="45" end="51" id="11"><surface>either</surface><lemma penn="DT"/><dependent governor="13" type="det"/></token><token begin="52" end="56" id="12"><surface>CoVs</surface><lemma penn="NNP"/><dependent governor="13" type="compound"/></token><token begin="57" end="68" id="13"><surface>diagnostics</surface><lemma penn="NNS">diagnostics</lemma><dependent governor="9" type="nmod"/></token><token begin="69" end="75" id="14"><surface>and/or</surface><lemma penn="CC"/><dependent governor="13" type="cc"/></token><token begin="76" end="80" id="15"><surface>CoVs</surface><lemma penn="NNS"/><dependent governor="13" type="conj"/></token><token begin="81" end="90" id="16"><surface>isolation</surface><lemma penn="NN">isolation</lemma><dependent governor="9" type="nmod:tmod"/></token><token begin="91" end="94" id="17"><surface>and</surface><lemma penn="CC"/><dependent governor="16" type="cc"/></token><token begin="95" end="102" id="18"><surface>vaccine</surface><lemma penn="NN">vaccine</lemma><dependent governor="19" type="compound"/></token><token begin="103" end="114" id="19"><surface>development</surface><lemma penn="NN">development</lemma><dependent governor="16" type="conj"/></token><token begin="115" end="118" id="20"><surface>all</surface><lemma penn="DT"/><dependent governor="21" type="nsubj"/></token><token begin="119" end="122" id="21"><surface>had</surface><lemma penn="VBD">have</lemma><dependent governor="6" type="acl:relcl"/></token><token begin="123" end="127" id="22"><surface>high</surface><lemma penn="JJ">high</lemma><dependent governor="23" type="amod"/></token><token begin="128" end="135" id="23"><surface>quality</surface><lemma penn="NN">quality</lemma><dependent governor="24" type="compound"/></token><token begin="136" end="145" id="24"><surface>biosafety</surface><lemma penn="NN">biosafety</lemma><dependent governor="25" type="compound"/></token><token begin="146" end="151" id="25"><surface>level</surface><lemma penn="NN">level</lemma><dependent governor="21" type="dobj"/></token><token begin="152" end="153" id="26"><surface>(</surface><lemma penn="-LRB-"/><dependent governor="27" type="punct"/></token><token begin="153" end="157" id="27"><surface>BSL3</surface><lemma penn="CD"/><dependent governor="6" type="appos"/></token><token begin="158" end="160" id="28"><surface>or</surface><lemma penn="CC"/><dependent governor="27" type="cc"/></token><token begin="161" end="162" id="29"><surface>4</surface><lemma penn="CD"/><dependent governor="27" type="conj"/></token><token begin="162" end="163" id="30"><surface>)</surface><lemma penn="-RRB-"/><dependent governor="27" type="punct"/></token><token begin="164" end="174" id="31"><surface>facilities</surface><lemma penn="NNS">facility</lemma><dependent governor="31" type="ROOT"/></token><token begin="175" end="179" id="32"><surface>that</surface><lemma penn="WDT"/><dependent governor="34" type="nsubj"/></token><token begin="180" end="184" id="33"><surface>were</surface><lemma penn="VBD">be</lemma><dependent governor="34" type="cop"/></token><token begin="185" end="197" id="34"><surface>well-managed</surface><lemma penn="JJ">well</lemma><dependent governor="31" type="acl:relcl"/></token><token begin="197" end="198" id="35"><surface>,</surface><lemma penn=","/><dependent governor="34" type="punct"/></token><token begin="199" end="203" id="36"><surface>with</surface><lemma penn="IN"/><dependent governor="41" type="case"/></token><token begin="204" end="205" id="37"><surface>a</surface><lemma penn="DT"/><dependent governor="41" type="det"/></token><token begin="206" end="211" id="38"><surface>staff</surface><lemma penn="NN">staff</lemma><dependent governor="40" type="compound"/></token><token begin="212" end="218" id="39"><surface>health</surface><lemma penn="NN">health</lemma><dependent governor="40" type="compound"/></token><token begin="219" end="229" id="40"><surface>monitoring</surface><lemma penn="NN">monitoring</lemma><dependent governor="41" type="compound"/></token><token begin="230" end="239" id="41"><surface>programme</surface><lemma penn="NN">programme</lemma><dependent governor="34" type="nmod"/></token><token begin="240" end="244" id="42"><surface>with</surface><lemma penn="IN"/><dependent governor="44" type="case"/></token><token begin="245" end="247" id="43"><surface>no</surface><lemma penn="DT"/><dependent governor="44" type="neg"/></token><token begin="248" end="257" id="44"><surface>reporting</surface><lemma penn="NN">reporting</lemma><dependent governor="41" type="nmod"/></token><token begin="258" end="260" id="45"><surface>of</surface><lemma penn="IN"/><dependent governor="46" type="case"/></token><token begin="261" end="269" id="46"><surface>COVID-19</surface><lemma penn="NNP"/><dependent governor="44" type="nmod"/></token><token begin="270" end="280" id="47"><surface>compatible</surface><lemma penn="JJ">compatible</lemma><dependent governor="49" type="amod"/></token><token begin="281" end="292" id="48"><surface>respiratory</surface><lemma penn="NN"/><dependent governor="49" type="compound"/></token><token begin="293" end="300" id="49"><surface>illness</surface><lemma penn="NN">illness</lemma><dependent governor="34" type="nmod:tmod"/></token><token begin="301" end="307" id="50"><surface>during</surface><lemma penn="IN"/><dependent governor="52" type="case"/></token><token begin="308" end="311" id="51"><surface>the</surface><lemma penn="DT"/><dependent governor="52" type="det"/></token><token begin="312" end="324" id="52"><surface>weeks/months</surface><lemma penn="NNS">week</lemma><dependent governor="34" type="nmod"/></token><token begin="325" end="330" id="53"><surface>prior</surface><lemma penn="RB"/><dependent governor="55" type="case"/></token><token begin="331" end="333" id="54"><surface>to</surface><lemma penn="TO"/><dependent governor="53" type="mwe"/></token><token begin="334" end="342" id="55"><surface>December</surface><lemma penn="NNP">december</lemma><dependent governor="34" type="nmod"/></token><token begin="343" end="347" id="56"><surface>2019</surface><lemma penn="CD"/><dependent governor="55" type="nummod"/></token><token begin="347" end="348" id="57"><surface>,</surface><lemma penn=","/><dependent governor="31" type="punct"/></token><token begin="349" end="352" id="58"><surface>and</surface><lemma penn="CC"/><dependent governor="31" type="cc"/></token><token begin="353" end="355" id="59"><surface>no</surface><lemma penn="DT"/><dependent governor="61" type="neg"/></token><token begin="356" end="367" id="60"><surface>serological</surface><lemma penn="JJ">serological</lemma><dependent governor="61" type="amod"/></token><token begin="368" end="376" id="61"><surface>evidence</surface><lemma penn="NN">evidence</lemma><dependent governor="31" type="conj"/></token><token begin="377" end="379" id="62"><surface>of</surface><lemma penn="IN"/><dependent governor="63" type="case"/></token><token begin="380" end="389" id="63"><surface>infection</surface><lemma penn="NN">infection</lemma><dependent governor="61" type="nmod"/></token><token begin="390" end="392" id="64"><surface>in</surface><lemma penn="IN"/><dependent governor="65" type="case"/></token><token begin="393" end="400" id="65"><surface>workers</surface><lemma penn="NNS">worker</lemma><dependent governor="63" type="nmod"/></token><token begin="401" end="408" id="66"><surface>through</surface><lemma penn="IN"/><dependent governor="68" type="case"/></token><token begin="409" end="428" id="67"><surface>SARS-CoV-2-specific</surface><lemma penn="JJ">specific</lemma><dependent governor="68" type="amod"/></token><token begin="429" end="447" id="68"><surface>serology-screening</surface><lemma penn="NN">serology</lemma><dependent governor="65" type="nmod"/></token><token begin="447" end="448" id="69"><surface>.</surface><lemma penn="."/><dependent governor="31" type="punct"/></token><annotation type="NP" begin="0" end="22" surface="The three laboratories"/><annotation type="PP" begin="23" end="25" surface="in"/><annotation type="NP" begin="26" end="31" surface="Wuhan"/><annotation type="VP" begin="32" end="39" surface="working"/><annotation type="PP" begin="40" end="44" surface="with"/><annotation type="NP" begin="45" end="114" surface="either CoVs diagnostics and/or CoVs isolation and vaccine development"/><annotation type="VP" begin="119" end="122" surface="had"/><annotation type="NP" begin="123" end="174" surface="high quality biosafety level (BSL3 or 4) facilities"/><annotation type="NP" begin="175" end="179" surface="that"/><annotation type="VP" begin="180" end="184" surface="were"/><annotation type="ADJP" begin="185" end="197" surface="well-managed"/><annotation type="PP" begin="199" end="203" surface="with"/><annotation type="NP" begin="204" end="239" surface="a staff health monitoring programme"/><annotation type="PP" begin="240" end="244" surface="with"/><annotation type="NP" begin="245" end="257" surface="no reporting"/><annotation type="PP" begin="258" end="260" surface="of"/><annotation type="NP" begin="261" end="300" surface="COVID-19 compatible respiratory illness"/><annotation type="PP" begin="301" end="307" surface="during"/><annotation type="NP" begin="308" end="324" surface="the weeks/months"/><annotation type="ADVP" begin="325" end="330" surface="prior"/><annotation type="PP" begin="331" end="333" surface="to"/><annotation type="NP" begin="334" end="347" surface="December 2019"/><annotation type="NP" begin="353" end="376" surface="no serological evidence"/><annotation type="PP" begin="377" end="379" surface="of"/><annotation type="NP" begin="380" end="389" surface="infection"/><annotation type="PP" begin="390" end="392" surface="in"/><annotation type="NP" begin="393" end="400" surface="workers"/><annotation type="PP" begin="401" end="408" surface="through"/><annotation type="NP" begin="409" end="447" surface="SARS-CoV-2-specific serology-screening"/><annotation type="semantic:Temporal" begin="334" end="347" surface="December 2019"/></sentence></document>